Autopsy report · NCT02968784
Focal ExAblate MR-Guided Focused Ultrasound Treatment for Management of Organ-Confined Intermediate Risk Prostate Cancer
Cause of deathFunding or business
“Sponsor Decision”
Life of this trial
- Registered 3 months after it had already started.
- Ran for about 6 years 8 months before it stopped.
- 53 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- InSightec
- Sponsor type
- Industry
- Conditions
- Prostate Cancer
- Interventions
- ExAblate MRgFUS
- Participants
- 53
- Sites
- 4
- Countries
- Canada, China, United Kingdom
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.